Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
investment
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Aenova Expands Fill & Finish Capacities at its Latina site
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Sharp Services Invests $100 Million in US and European Facilities
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex Invests $120 Million to Expand US API Manufacturing
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
ACG Invests $200 Million in US Hard-Shell Capsule Manufacturing
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
20.10.2025 • News • Innovation
Brenntag Specialties Opens New Innovation & Application Center for Food & Nutrition in UK
The Leeds Innovation & Application Center is the newest of the now 71 Brenntag Specialties innovation centers globally, 31 of which focus on Food & Nutrition.
17.10.2025 • News
Roquette Opens Pharmaceutical Innovation Center in Brazil
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
14.10.2025 • News
Clariant Expands Production Capacities in Daya Bay
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Polyvantis Opens Shanghai Technology Center
Polyvantis has opened a new Technology Center in Shanghai, China, to unite R&D, commercial, and manufacturing teams and accelerate innovation for optical and electrical film solutions.
06.10.2025 • News • Bioprocessing
Fujifilm Biotechnologies Opens its Commercial-Scale Cell Culture US Manufacturing Site
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
01.10.2025 • News
Henkel Expands US Facility to Boost EV and Electronics Manufacturing
Henkel has doubled the size of its South Dakota plant to increase production of thermal management materials for the electric vehicle and electronics markets.
01.10.2025 • News
Arkema Opens Battery Dry Coating Laboratory
Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.
30.09.2025 • News
AbbVie Breaks Ground on US API Manufacturing Facility
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
29.09.2025 • News • Bioprocessing
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly to Build $6.5 Billion US Pharmaceutical Plant
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
BASF Launches CO₂-Free Steam Heat Pump Project at Ludwigshafen
BASF and cooperation partner GIG Karasek have celebrated the symbolic ground-breaking ceremony for one of the world's largest industrial heat pumps for CO2-free steam generation at the Ludwigshafen site.
23.09.2025 • News • Bioprocessing
Merck Opens Life Science Production Plant in Ireland
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
19.09.2025 • News
Solvay Restructures German Operations, Invests €25 Million
Solvay strengthens its competitiveness in Germany through portfolio realignment and investments.
GSK to Invest $30 Billion in US R&D and Manufacturing
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
LGC Opens $100 Million Pharma Synthesis Center in Canada
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
Gilead Breaks Ground on New US Manufacturing Hub
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
04.09.2025 • News
Honeywell’s Quantinuum Secures $600 Million Funding, Gains Nvidia as Investor
Honeywell’s Quantinuum has raised $600 million at a $10 billion valuation, with Nvidia and other key investors backing the company to accelerate development of advanced quantum technologies and global partnerships.
02.09.2025 • News
Vioneo and ECI Group to Build World’s First Fossil-Free LDPE Plant in Belgium
Vioneo awards ECI Group contract to build world’s first LDPE plant using entirely fossil-free feedstock.
Genentech and Roche Break Ground on US Manufacturing Facility
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
Cambrex Expands Peptide Manufacturing Capabilities in US
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
29.08.2025 • News
Arkema Invests $60 Million in New Fluorospecialties Production Unit in the US
With the start-up of its production unit in Kentucky, Arkema develops its low Global Warming Potential (GWP) fluorospecialties to meet demand for more sustainable solutions in building insulation and thermal management.
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
Sumitomo Scales Up Ethanol-to-Propylene Process
Sumitomo Chemical has constructed and begun operation of a pilot facility at the Sodegaura site of its Chiba Works for its new proprietary process to produce propylene directly from ethanol.
14.08.2025 • News
Nouryon Expands Sodium Chlorate Capacity in South America by 20%
Nouryon has signed a long-term agreement with Arauco for the supply of sodium chlorate and chlorine dioxide for Arauco's new $4.6 billion pulp mill in Mato Grosso do Sul, Brazil.
AbbVie Invests $195 Million in US API Production
AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.
Chevron Phillips Chemical Completes PAO Expansion in Belgium
Chevron Phillips Chemical has successfully completed the expansion of its low-viscosity polyalphaolefins production unit in Beringen, Belgium, boosting its manufacturing capacity in Europe.
12.08.2025 • News • Bioprocessing
Bionova Scientific Opens New pDNA Facility in Texas
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
29.07.2025 • News • Bioprocessing
Asahi Kasei Expands Planova Production with New Spinning Plant
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
Boehringer Ingelheim Paves the Way for Important Market Launches
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.
Messer Group GmbH
ACG
Ineos
Nippon Shokubai Co., Ltd.
Capchem Technology USA Inc.
Avantor
Bayer AG
Arkema
Kyowa Kirin Co., Ltd.
Gilead Sciences, Inc.
Petronas
Vynova Group
ECI Group
LGC Group
Merck & Co
LyondellBasell
Perstorp Holding AB
Sterling Pharma Solutions
Olon S.p.A.
Brenntag SE
Lonza AG
Sanner GmbH
GlaxoSmithKline (GSK) plc
Sygnature Discovery
DuPont Company
Evonik Industries AG
Elixir Group DOO
International Flavors & Fragrances Inc. (IFF)
Thyssenkrupp Nucera AG & Co. KGaA
Aenova Holding GmbH
Asahi Kasei Europe
Novo Nordisk Pharmatech A/S
Honeywell International Inc.
Merck KGaA
Upperton Pharma Solutions
Aragen Life Sciences Ltd.
Integrals Power
Samsung Biologics
BASF SE
Roche Group
Solvay
ISPE D/A/CH e.V.
Sandoz AG
Trinseo LLC
TotalEnergies SE
Veranova
Sanofi S.A.
Umicore AG & Co. KG
Accenture
Orion S.A.